These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1977490)

  • 21. Sulphasalazine in the treatment of rheumatoid arthritis: a renewed challenge.
    van Riel PL; van de Putte LB
    Neth J Med; 1990 Jun; 36(5-6):221-2. PubMed ID: 1975649
    [No Abstract]   [Full Text] [Related]  

  • 22. Psoriasis-like skin reaction in a patient with rheumatoid arthritis after sulphasalazine therapy.
    Bliddal H; Stangerup M
    Clin Rheumatol; 1991 Jun; 10(2):178-80. PubMed ID: 1680596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sulphasalazine in rheumatoid arthritis: haematological problems and changes in haematological indices associated with therapy.
    Farr M; Tunn EJ; Symmons DP; Scott DG; Bacon PA
    Br J Rheumatol; 1989 Apr; 28(2):134-8. PubMed ID: 2565128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experience with sulphasalazine (salazopyrin) in the treatment of rheumatoid arthritis].
    Winkler V
    Orv Hetil; 1986 Aug; 127(34):2073-4, 2079-80. PubMed ID: 2876405
    [No Abstract]   [Full Text] [Related]  

  • 25. Sulphasalazine induced agranulocytosis in a patient with rheumatoid arthritis.
    Murphy PT; O'Donnell JR
    Ir J Med Sci; 1990 Jun; 159(6):195. PubMed ID: 1977725
    [No Abstract]   [Full Text] [Related]  

  • 26. Toleration, side-effects and efficacy of sulphasalazine in rheumatoid arthritis patients of different ages.
    Wilkieson CA; Madhok R; Hunter JA; Capell HA
    Q J Med; 1993 Aug; 86(8):501-5. PubMed ID: 8105504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Raised serum alkaline phosphatase and aspartate transaminase levels in two rheumatoid patients treated with sulphasalazine.
    Farr M; Symmons DP; Bacon PA
    Ann Rheum Dis; 1985 Nov; 44(11):798-800. PubMed ID: 2865931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sulphasalazine in rheumatoid arthritis: an old drug revived.
    Neumann VC; Grindulis KA
    J R Soc Med; 1984 Mar; 77(3):169-72. PubMed ID: 6142116
    [No Abstract]   [Full Text] [Related]  

  • 29. Long term outcome of treatment with sulphasalazine in rheumatoid arthritis.
    Situnayake RD; McConkey B
    Drugs; 1986; 32 Suppl 1():71-2. PubMed ID: 2877857
    [No Abstract]   [Full Text] [Related]  

  • 30. Adverse interaction between intramuscular methylprednisolone and sulphasalazine in patients with early rheumatoid arthritis. A pilot study.
    Gough A; Sheeran T; Arthur V; Panayi G; Emery P
    Scand J Rheumatol; 1994; 23(1):46-8. PubMed ID: 7906428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does sulphasalazine cause folate deficiency in rheumatoid arthritis?
    Grindulis KA; McConkey B
    Scand J Rheumatol; 1985; 14(3):265-70. PubMed ID: 2864741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrocytic anaemia in patients treated with sulphasalazine for rheumatoid arthritis.
    Prouse PJ; Shawe D; Gumpel JM
    Br Med J (Clin Res Ed); 1986 Nov; 293(6559):1407. PubMed ID: 2879599
    [No Abstract]   [Full Text] [Related]  

  • 33. Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine, or dapsone.
    Grindulis KA; McConkey B
    Ann Rheum Dis; 1984 Jun; 43(3):398-401. PubMed ID: 6146295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Which component of sulphasalazine is active in rheumatoid arthritis?
    Pullar T; Hunter JA; Capell HA
    Br Med J (Clin Res Ed); 1985 May; 290(6481):1535-8. PubMed ID: 2860942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variables affecting efficacy and toxicity of sulphasalazine in rheumatoid arthritis. A review.
    Pullar T; Capell HA
    Drugs; 1986; 32 Suppl 1():54-7. PubMed ID: 2877854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy.
    Pullar T; Hunter JA; Capell HA
    Br J Rheumatol; 1985 Aug; 24(3):269-76. PubMed ID: 2861876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The three week sulphasalazine syndrome.
    Brooks H; Taylor HG; Nichol FE
    Clin Rheumatol; 1992 Dec; 11(4):566-8. PubMed ID: 1362531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis.
    Porter D; Madhok R; Hunter JA; Capell HA
    Ann Rheum Dis; 1992 Apr; 51(4):461-4. PubMed ID: 1350192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical efficacy of sulphasalazine in rheumatic disease.
    Taggart AJ
    Agents Actions Suppl; 1988; 24():189-96. PubMed ID: 2903619
    [No Abstract]   [Full Text] [Related]  

  • 40. Sulphasalazine therapy in rheumatoid arthritis. A two-year study and follow-up of clinical results.
    Georgescu C
    Rom J Intern Med; 1992; 30(2):127-32. PubMed ID: 1353901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.